3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
36
Neoplasms
32
Prostatic Neoplasms
26
Colorectal Neoplasms
25
Lung Neoplasms
21
Carcinoma, Non-Small-Cell Lung
16
Hematologic Neoplasms
13
Neoplasm Metastasis
10
Pancreatic Neoplasms
9
Ovarian Neoplasms
8
Multiple Myeloma
8
Head and Neck Neoplasms
8
Urinary Bladder Neoplasms
7
Triple Negative Breast Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
7
Hematopoietic and Lymphatic System Neoplasm
7
Stomach Neoplasms
6
Carcinoma, Renal Cell
6
Anatomic Stage I Breast Cancer AJCC v8
6
Uterine Cervical Neoplasms
5
Sarcoma
5
Glioma
5
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Mouth Neoplasms
4
Motor Activity
4
Melanoma
4
Leukemia, Myeloid, Acute
4
Hematopoietic and Lymphoid System Neoplasm
4
Head and Neck Carcinoma
4
Gastrointestinal Neoplasms
4
Interventions
Gemcitabine
16
Mitomycin
10
Docetaxel
6
BCG Vaccine
6
erdafitinib
5
durvalumab
4
dodecyl maltoside
4
Cystoscopy
4
ALT-803
4
Radiotherapy
2
5-aminolevulinic acid hexyl ester
2
viscum album peptide
1
tremelimumab
1
toripalimab
1
pirarubicin
1
pemigatinib
1
monalizumab
1
hydroxycamptothecinum
1
enfortumab vedotin
1
chondroitin sulfate, sodium hyaluronate drug combination
1
bicalutamide
1
Watchful Waiting
1
Urine Specimen Collection
1
Transurethral Resection of Bladder
1
Surveys and Questionnaires
1
Patient Discharge
1
Paclitaxel
1
Nonsteroidal Anti-Androgens
1
Mitozytrex
1
Maintenance
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Non-Muscle Invasive Bladder Neoplasms
×
Standard of Care
×
1 year
×
Clear all
No trials found.